United Kingdom

April 13, 2017April 13, 2017

Scottish Medicines Consortium Approves Zinbryta for NHS Treatment of RRMS Patients in Scotland

News

The United Kingdom’s National Institute for Health and Care Excellence (NICE) last month recommended Zinbryta (daclizumab) to treat relapsing-remitting multiple sclerosis (RRMS) in England and Wales. On April 10, Scotland received Scottish Medicines ... Read more

March 30, 2017March 30, 2017

Hope, But No Cheers Yet, Voiced by MS Groups in Europe and Canada Waiting on Own Ocrevus Decision

News

American patient groups and neurologists have clearly been giving Ocrevus (ocrelizumab) plenty of attention since news of its approval landed, as a sweep of U.S. reaction to the ... Read more

October 18, 2016October 18, 2016

MS Society Awards Almost $220K to Research into Myelin Repair and Renewal

News

The MS Society in the United Kingdom awarded £177,930 (about $217,800) to Dr. Sassan Hafizi, a researcher at University of Portsmouth, to investigate the potentially beneficial role of ... Read more

October 5, 2016October 12, 2016

MS Trust to Oppose NICE Plan to Reject Zinbryta as MS Therapy in Health System for England, Wales

News

The Multiple Sclerosis (MS) Trust is expressing its disappointment at the recent committee decision of the National Institute for Health and Care Excellence (NICE) to not recommend Zinbryta (daclizumab) be made available ... Read more

November 19, 2014November 19, 2014

‘Treat Me Right’ MS Society Campaign Shortlisted For Award

Multiple Sclerosis News, News

The Treat Me Right campaign from the MS Society in the UK was recently shortlisted for this year’s voluntary sector campaign Public Affairs Award. The campaign was launched in April 2014 during MS ... Read more

Pin It on Pinterest